Alimera Sciences is a pharmaceutical company that develops and sells ophthalmic pharmaceuticals, including ILUVIEN, an implant for the treatment of diabetic macular edema and recurrent non-infectious uveitis. The company collaborates with EyePoint Pharmaceuticals for the development and sale of insert technology to treat eye diseases. It sells its products through direct sales and distributors to physician offices, pharmacies, and hospitals. Alimera Sciences was founded in 2003 and is based in Alpharetta, Georgia.